Cantor Sees Possible Acquisitions For Valeant Pharmaceuticals In 2015
December 30, 2014 at 15:00 PM EST
Cantor Fitzgerald analyst Daniel Brims commented Tuesday that Valeant Pharmaceuticals Intl Inc. (NYSE: VRX) may make dental ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.